In the last trading session, 1.06 million shares of the Larimar Therapeutics Inc (NASDAQ:LRMR) were traded, and its beta was 1.03. Most recently the company’s share price was $10.49, and it changed around $0.69 or 7.04% from the last close, which brings the market valuation of the company to $669.26M. LRMR currently trades at a discount to its 52-week high of $13.68, offering almost -30.41% off that amount. The share price’s 52-week low was $2.18, which indicates that the current value has risen by an impressive 79.22% since then. We note from Larimar Therapeutics Inc’s average daily trading volume that its 3-month average coming to 552.85K.
Larimar Therapeutics Inc (NASDAQ:LRMR) trade information
Instantly LRMR has showed a green trend with a performance of 7.04% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently up 130.55% year-to-date, but still up 38.21% over the last five days. On the other hand, Larimar Therapeutics Inc (NASDAQ:LRMR) is 12.31% up in the 30-day period.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target as assigned by Wall Street analysts is $14.5, which translates to bulls needing to increase their stock price by 27.66% from its current value. Analyst projections state that LRMR is forecast to be at a low of $4 and a high of $25.
Larimar Therapeutics Inc (LRMR) estimates and forecasts
Larimar Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 128.04 percent over the past six months and at a -53.57% annual growth rate that is well below the industry average of 13.90%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 48.33%.
LRMR Dividends
Larimar Therapeutics Inc’s next quarterly earnings report is expected to be released in August.
